
When to Start People with Diabetes on Insulin
Key indicators and timing for insulin initiation in Type 2 diabetes care pathways
This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content may only be relevant to HCPs practising in Great Britain (England, Scotland and Wales) according to product availability. This website is optimised for desktop use, and some features may perform differently on mobile devices.
Adverse event reporting can be found at the bottom of the page.


Key indicators and timing for insulin initiation in Type 2 diabetes care pathways

.png)
Trurapi®▼ (insulin aspart 100 units/mL)

REZUROCK®▼(belumosudil)



Beyfortus®▼ (nirsevimab)

MAT-XU-2305061 (v2.0) Date of preparation: February 2024